AMH Equity Ltd
- SEC CIK
- 0001600535
- Latest filing
- Oct 29, 2025
HBIO holding history
Harvard Bioscience Inc in every 13F filed by AMH Equity Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HBIO overviewAll 13F holders of HBIOFull Q3 2025 holdings
- Shares (Q3 2025)
- 4,047,535
- Value
- $1.77M
- % of portfolio
- 2.2%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 4,047,535 | $1.77M | 2.2% | +538,832+15.4% | Added | Holders |
| Q2 2025 | 3,508,703 | $1.56M | 2.3% | +121,348+3.6% | Added | Holders |
| Q1 2025 | 3,387,355 | $1.92M | 3.0% | +887,355+35.5% | Added | Holders |
| Q4 2024 | 2,500,000 | $5.28M | 5.4% | +111,132+4.7% | Added | Holders |
| Q3 2024 | 2,388,868 | $6.43M | 8.5% | +188,946+8.6% | Added | Holders |
| Q2 2024 | 2,199,922 | $6.27M | 9.3% | −124,278−5.3% | Reduced | Holders |
| Q1 2024 | 2,324,200 | $9.85M | 10.9% | +161,307+7.5% | Added | Holders |
| Q4 2023 | 2,162,893 | $11.6M | 12.4% | +21,540+1.0% | Added | Holders |
| Q3 2023 | 2,141,353 | $9.21M | 11.7% | +141,353+7.1% | Added | Holders |
| Q2 2023 | 2,000,000 | $11.0M | 12.6% | −53,907−2.6% | Reduced | Holders |
| Q1 2023 | 2,053,907 | $8.63M | 11.8% | −200,000−8.9% | Reduced | Holders |
| Q4 2022 | 2,253,907 | $6.24M | 9.3% | +633,124+39.1% | Added | Holders |
| Q3 2022 | 1,620,783 | $4.15M | 7.4% | +370,783+29.7% | Added | Holders |
| Q2 2022 | 1,250,000 | $4.50M | 8.9% | +473,747+61.0% | Added | Holders |
| Q1 2022 | 776,253 | $4.82M | 5.8% | −23,747−3.0% | Reduced | Holders |
| Q4 2021 | 800,000 | $5.64M | 8.2% | – | No prior filing | Holders |